Transfusion Related Complication Clinical Trial
— CB-TrIPOfficial title:
Fetal Hemoglobin Levels and Umbilical Cord or Adult Blood RBC Transfusions in Preterm Neonates.
Verified date | August 2021 |
Source | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Repeated transfusions have been associated with very poor outcome of preterm infants. Fetal hemoglobin (HbF) and adult Hb (HbA) have different affinity for oxygen. The high level of adult Hb may contribute to exacerbating the oxidative damage responsible for prematurity diseases. The investigators hypothesized that transfusing red blood cells (RBC) obtained from allogeneic cord blood (CB) of healthy full-term babies (which contains almost exclusively HbF) may prevent the non-physiological decrease of HbF in premature neonates, likewise protecting them from oxygen radical diseases. Cord blood transfusion in preterms - CB TRIP - is a monocentric prospective nonrandomized study aimed to monitor HbF levels in preterm neonates receiving RBC transfusions from either umbilical blood of full-term healthy babies (CB-RBC) and/or from adult donors (A-RBC).
Status | Completed |
Enrollment | 25 |
Est. completion date | August 2, 2019 |
Est. primary completion date | August 2, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: preterm neonates born at PMA =30 weeks and/or with birth weight =1000 g born at the delivery room of Fondazione Policlinico Universitario A. Gemelli candidate to receive one or more RBC unit transfusion. Exclusion Criteria: One or more of the following criteria Maternal-fetal immunization Hydrops fetalis Major congenital malformations associated or not with genetic syndromes Previous transfusions Hemorrhage at birth Congenital infections (such as infections from TORCH complex) Out-born infants The health care team deems it inappropriate to approach the infant's family for informed consent |
Country | Name | City | State |
---|---|---|---|
Italy | Fondazione Policlinico Universitario A. Gemelli IRCCS | Roma | RM |
Italy | Fondazione Policlinico Universitario A.Gemelli IRCCS | Rome |
Lead Sponsor | Collaborator |
---|---|
Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
Italy,
Bianchi M, Giannantonio C, Spartano S, Fioretti M, Landini A, Molisso A, Tesfagabir GM, Tornesello A, Barbagallo O, Valentini CG, Vento G, Zini G, Romagnoli C, Papacci P, Teofili L. Allogeneic umbilical cord blood red cell concentrates: an innovative blood product for transfusion therapy of preterm infants. Neonatology. 2015;107(2):81-6. doi: 10.1159/000368296. Epub 2014 Nov 15. — View Citation
Bianchi M, Papacci P, Valentini CG, Barbagallo O, Vento G, Teofili L. Umbilical cord blood as a source for red-blood-cell transfusion in neonatology: a systematic review. Vox Sang. 2018 Nov;113(8):713-725. doi: 10.1111/vox.12720. Epub 2018 Oct 16. — View Citation
dos Santos AM, Guinsburg R, de Almeida MF, Procianoy RS, Leone CR, Marba ST, Rugolo LM, Fiori HH, Lopes JM, Martinez FE; Brazilian Network on Neonatal Research. Red blood cell transfusions are independently associated with intra-hospital mortality in very low birth weight preterm infants. J Pediatr. 2011 Sep;159(3):371-376.e1-3. doi: 10.1016/j.jpeds.2011.02.040. Epub 2011 Apr 13. — View Citation
Stutchfield CJ, Jain A, Odd D, Williams C, Markham R. Foetal haemoglobin, blood transfusion, and retinopathy of prematurity in very preterm infants: a pilot prospective cohort study. Eye (Lond). 2017 Oct;31(10):1451-1455. doi: 10.1038/eye.2017.76. Epub 2017 May 26. — View Citation
Valieva OA, Strandjord TP, Mayock DE, Juul SE. Effects of transfusions in extremely low birth weight infants: a retrospective study. J Pediatr. 2009 Sep;155(3):331-37.e1. doi: 10.1016/j.jpeds.2009.02.026. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Median Percentage of HbF at 32 Weeks of Post Menstrual Age | The HbF level was determined by high-performance liquid chromatography and was expressed as percentage of total Hb, calculated as the sum of fetal and adult Hb, according to the formula: HbF= [HbF/ (FHbA1 + HbA2 + HbF)]. HbF. | From study entry to the completion of postmenstrual age of 32 weeks | |
Secondary | Post-transfusion Hematocrit (Htc) Change | Change from baseline of Htc observed after either adult-RBC or cord-RBC transfusions. To this purpose, analysis was carried out between the two groups of RBC transfusions and patients were accordingly redistributed. | From enrollment to last HbF assessment occurring at 36 weeks, discharge or death | |
Secondary | Intervals Between Transfusions | Number of days between two consecutive transfusions.To this purpose, analysis was carried out between the two groups of RBC transfusions and patients were accordingly redistributed. | From enrollment to the last HbF assessment occurring at 36 weeks, discharge or death | |
Secondary | Median Percentage of HbF at Last Assessment | Median percentage of HbF at last HbF assessment. The last HbF measure was obtained at the completion of the 36 week of age, discharge or death. | From enrollment to the last HbF assessment occurring at 36 weeks, discharge or death |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05699005 -
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
|
Phase 1 | |
Recruiting |
NCT06403163 -
Transfusion Surveillance in Anaesthesia
|
||
Not yet recruiting |
NCT02587845 -
Use of Transexamic Acid in Hip Replacement
|
Phase 3 | |
Completed |
NCT03365999 -
Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.
|
Phase 2 | |
Completed |
NCT03784794 -
Patient Blood Management for Massive Obstetric Hemorrhage
|
N/A | |
Not yet recruiting |
NCT02139995 -
West-China Transfusion Score for Critically-ill Patients
|
Phase 3 | |
Completed |
NCT04513249 -
Effects of Therapeutic Plasmaexhange on Viscoelastic Tests in Non-coagulopathic Patients
|
||
Not yet recruiting |
NCT03934112 -
Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit
|
||
Completed |
NCT03394274 -
Restrictive Versus Liberal Transfusion, Major Surgeries
|
N/A | |
Not yet recruiting |
NCT06399536 -
Individualized ANH for Non-cardiac Surgery
|
N/A | |
Withdrawn |
NCT04388722 -
Monitoring Noninvasively for Infusion and Transfusion Optimization
|
N/A | |
Completed |
NCT03476005 -
Proficiency Based Training to Investigate WBIT
|
N/A | |
Recruiting |
NCT03999229 -
S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
|
Phase 1 | |
Not yet recruiting |
NCT04413721 -
Effects of Packed Red Blood Cell Storage Duration on Pediatric Living Donor Liver Transplantation
|
N/A | |
Recruiting |
NCT02461264 -
Transfusion Strategy in Hematological Intensive Care Unit
|
Phase 3 | |
Terminated |
NCT01915654 -
Impact of RBC Transfusion Less Than 14 Days on Morbidity and Mortality in Cardiac Surgical Patients
|
N/A | |
Not yet recruiting |
NCT05696210 -
Evaluation of the 1-year Prognosis of Patients Under Veno-arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock With Blood Transfusion Requirement
|
||
Completed |
NCT04286984 -
Implementation of a Patient Blood Management Program in Gastric Cancer Surgery
|
||
Withdrawn |
NCT04383756 -
Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation
|
Early Phase 1 | |
Completed |
NCT03815773 -
PRospective Multicenter Observational Study on Transfusion Practice in Vv-ECMO Patients: The PROTECMO Study
|